Does lipoprotein(a) (Lp(a)) compete with plasminogen in human atherosclerotic lesions and thrombi?
- 31 August 1991
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 89 (2-3), 127-136
- https://doi.org/10.1016/0021-9150(91)90052-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham StudyAmerican Heart Journal, 1987
- Physiologic regulation and pathologic disorders of fibrinolysisHuman Pathology, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Thrombosis and ischaemic heart disease.Heart, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Insoluble “fibrin” in human aortic intima: Quantitative studies on the relationship between insoluble “fibrin”, soluble fibrinogen and low density lipoproteinAtherosclerosis, 1976
- Altered Endogenous Fibrinolysis and Biochemical Factors in AtherosclerosisArchives of Surgery, 1974
- FIBRINOLYTIC ACTIVITY OF THE BLOOD IN INTERMITTENT CLAUDICATIONThe Lancet, 1959
- Thrombosis as a factor in the pathogenesis of aortic atherosclerosisThe Journal of Pathology and Bacteriology, 1948